|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6980 EUR | +36.59% |
|
+23.76% | -54.56% |
| 13/07 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 11/07 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +36.59% | +23.76% | -22.27% | -39.62% | -54.56% | -56.65% | -82.44% | -95.22% | -94.96% | 46.55M | |
| +0.41% | +6.05% | +1.97% | +19.69% | +25.34% | +56.95% | +25.33% | +69.47% | +125.14% | 324B | |
| +1.87% | +5.04% | -3.18% | +29.87% | +15.62% | +25.39% | -11.68% | -17.68% | +44.38% | 68.88B | |
| +0.02% | +6.79% | +6.67% | +27.66% | +22.33% | +42.60% | +89.21% | +100.11% | +729.05% | 9.72B | |
| +1.64% | +0.24% | +4.41% | +13.16% | +5.30% | +3.68% | -2.03% | -28.76% | +38.88% | 8.37B | |
| +1.61% | +3.15% | -1.21% | -19.94% | -34.27% | -20.18% | -2.50% | -32.03% | - | 4.32B | |
| -3.87% | +1.69% | +8.43% | -24.05% | -35.94% | -41.18% | +16.67% | +35.09% | +77.00% | 3.83B | |
| +3.53% | +4.27% | +4.32% | +22.20% | +29.32% | -2.33% | +16.83% | -33.55% | - | 3.62B | |
| +2.37% | +0.32% | +1.65% | -3.82% | -4.29% | +42.38% | +57.88% | +74.70% | +115.54% | 2.68B | |
| +3.60% | +1.06% | +3.70% | -18.03% | -17.38% | -4.72% | -7.73% | +51.81% | - | 2.04B | |
| +1.63% | +2.54% | +19.67% | -3.86% | -1.92% | -14.93% | +26.76% | -27.15% | - | 1.84B | |
| +2.24% | -2.26% | +11.31% | -10.81% | -14.26% | -22.40% | -20.84% | -8.26% | -43.95% | 1.68B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| +0.36% | +4.07% | +16.36% | +82.26% | +152.75% | +184.36% | +1,471.32% | +692.95% | - | 1.17B | |
| +12.43% | +14.56% | +8.99% | -33.48% | -32.74% | +53.22% | +60.53% | +34.07% | +516.27% | 1.13B | |
| +0.92% | -5.21% | -3.55% | -29.86% | -20.23% | -37.23% | -33.53% | - | - | 1.12B | |
| +4.13% | -1.29% | +5.40% | +9.13% | +14.57% | +5.89% | +88.34% | +10.29% | - | 1.1B | |
| +1.65% | +3.24% | +5.52% | -5.81% | -7.53% | -0.69% | +43.33% | +89.43% | +83.29% | 1.07B | |
| +3.09% | -2.65% | +5.67% | -19.70% | -23.91% | -40.41% | -77.29% | -83.31% | - | 850M | |
| +3.40% | +2.53% | +7.52% | -13.21% | -12.59% | -42.00% | -10.99% | -46.24% | -65.58% | 840M | |
| Average | +3.88% | -0.12% | +4.28% | -0.96% | +0.30% | +6.93% | +86.69% | +43.65% | +138.64% | 21.98B | |
| Weighted average by Cap. | +0.75% | +2.53% | +1.55% | +19.72% | +21.41% | +46.99% | +23.57% | +52.55% | +123.52% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
